Skip to main content

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Names New Senior VP

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that Matt Alberico has joined the company as a new senior vice president of growth. In his new role, Alberico will leverage his deep sales strategy experience in rapid-growth environments to help guide the company as it capitalizes on rapidly growing opportunities across several different markets. Alberico has an impressive background, including a stint at Amazon Care leading national channel sales and partnerships. In addition, he has served at both Cigna and Aetna in sales and account management leadership roles. According to the company, Alberico was granted a nonqualified stock option award to purchase 100,000 shares of Dario common stock as well as an additional nonqualified performance-based stock option award to purchase an additional 100,000 shares of the company’s common stock. The announcement noted that the options were granted as an “inducement material” to Alberico becoming an employee. “Matt brings the skills necessary to help Dario capitalize on the strong demand in the market and the deep network connections to accelerate the growth of our leading multi-chronic digital health solution,” said DarioHealth president Rick Anderson in the press release. “I’m excited for Matt to join at this juncture in our growth, as we recently signed our 100th contract and the market demand for integrated solutions continues to grow. His experience will be extremely valuable to position Dario for long-term success.”

To view the full press release, visit https://ibn.fm/m6jAt

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.